Tenascin-C aptamers are generated using tumor cells and purified protein.

@article{Hicke2001TenascinCAA,
  title={Tenascin-C aptamers are generated using tumor cells and purified protein.},
  author={Brian J Hicke and C. Marion and Yi Fang Chang and Ty Gould and Cynthia K Lynott and D L Parma and P. G. Schmidt and S. Warren},
  journal={The Journal of biological chemistry},
  year={2001},
  volume={276 52},
  pages={48644-54}
}
Tenascin-C (TN-C) is an extracellular matrix protein that is overexpressed during tissue remodeling processes, including tumor growth. To identify an aptamer for testing as a tumor-selective ligand, SELEX (systematic evolution of ligands by exponential enrichment) procedures were performed using both TN-C and TN-C-expressing U251 glioblastoma cells. The different selection techniques yielded TN-C aptamers that are related in sequence. In addition, a crossover procedure that switched from tumor… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 94 extracted citations

Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications

International journal of molecular sciences • 2017
View 5 Excerpts
Highly Influenced

Aptamers: A promising chemical antibody for cancer therapy

Oncotarget • 2016
View 4 Excerpts
Highly Influenced

Application of Aptamers for Targeted Therapeutics

Archivum Immunologiae et Therapiae Experimentalis • 2013
View 4 Excerpts
Highly Influenced

Characterisation of aptamers for therapeutic studies.

Expert opinion on drug discovery • 2007
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…